Richard S. Eiswirth's most recent trade in Alimera Sciences Inc. was a trade of 14,700 Restricted Stock Units done . Disclosure was reported to the exchange on March 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alimera Sciences Inc. | Richard S. Eiswirth | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 14,700 | 14,700 | - | - | Restricted Stock Units | |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2023 | 186,000 | 322,518 (6%) | 3% | 0 | Common Stock | |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 4.44 per share. | 31 Oct 2022 | 500 | 136,518 (2%) | 0% | 4.4 | 2,219 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.76 per share. | 29 Apr 2022 | 500 | 136,018 (2%) | 0% | 3.8 | 1,879 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 75,000 | 75,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 25,000 | 135,518 (2%) | 0% | 0 | Common Stock | |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 15 Dec 2021 | 484 | 110,518 (2%) | 0% | 4.5 | 2,177 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.89 per share. | 02 Dec 2021 | 5,000 | 105,034 (2%) | 0% | 4.9 | 24,428 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.41 per share. | 04 Nov 2021 | 10,086 | 98,634 (1%) | 0% | 4.4 | 44,446 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 04 Nov 2021 | 1,400 | 100,034 (2%) | 0% | 5.5 | 7,700 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.45 per share. | 03 Nov 2021 | 28,005 | 88,548 (1%) | 0% | 4.5 | 124,745 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.76 per share. | 29 Oct 2021 | 500 | 60,543 (1%) | 0% | 3.8 | 1,879 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.56 per share. | 30 Apr 2021 | 500 | 60,043 (1%) | 0% | 3.6 | 1,781 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 52,500 | 52,500 | - | - | Common Stock | |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 17,500 | 59,543 (1%) | 0% | 0 | Common Stock | |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 02 Nov 2020 | 2,500 | 42,043 (0%) | 0% | 4.2 | 10,377 | Common Stock |
| Alimera Sciences Inc. | Richard S. Eiswirth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.56 per share. | 30 Oct 2020 | 500 | 39,543 (0%) | 0% | 3.6 | 1,781 | Common Stock |